Study of Meloxicam Capsules to Treat Osteoarthritis Pain

Inclusion Criteria:

- Primary diagnosis of Functional Class I-III OA of the hip or knee

- Chronic user of nonsteroidal anti-inflammatory drugs (NDAIDs) and/or acetaminophen
for OA pain

- Discontinued all analgesic therapy at Screening

- For women of child-bearing potential: a woman who is not pregnant and not nursing,
and who is practicing an acceptable method of birth control

Exclusion Criteria:

- History of allergic reaction or clinically significant intolerance to acetaminophen,
aspirin, or any NSAIDs, including meloxicam

- Requires continuous use of opioid or opioid combination products to control OA pain
of the knee or hip

- Clinically significant unstable cardiac, respiratory, neurological, immunological,
hematological, or renal disease

- Significant difficulties swallowing capsules or unable to tolerate oral medication

- Previous participation in another clinical study of Meloxicam Capsules or received
any investigational drug or device or investigational therapy within 30 days before
Screening